Author

Alghamdi M

26 سبتمبر 2020
أداة لقياس الأثر الاقتصادي للتخلص من التهاب الكبد B: دراسة حالة في المملكة العربية السعودية
Summary Background No virologic cure exists for hepatitis B virus (HBV) infection, and existing therapies are designed to control viral replication. We aimed to estimate the national prevalence of HBsAg in 2017 and study the impact of an enhanced diagnosis rate and universal treatment administration on HBV-related outcomes in Saudi Arabia. Materials and methods A […]

Read More
1 يونيو 2018
عبء مرض الكبد الدهني غير الناجم عن شرب الكحول - المملكة العربية السعودية والإمارات العربية المتحدة ، 2017-2030
Summary Background/Aim Due to epidemic levels of obesity and type 2 diabetes mellitus (DM), nonalcoholic fatty liver disease (NAFLD) and resulting nonalcoholic steatohepatitis (NASH) will be driving factors in liver diseaseburden in the coming years in Saudi Arabia and United Arab Emirates (UAE). Materials and Methods Models were used to estimate NAFLD and NASH disease […]

Read More